HUTCHMED (China) Limited
HMDCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.15 | -0.25 | -0.09 | -0.62 |
| FCF Yield | -0.64% | 5.75% | -12.01% | -5.46% |
| EV / EBITDA | 188.72 | 45.20 | -5.61 | -17.91 |
| Quality | ||||
| ROIC | -3.70% | 1.93% | -60.46% | -33.78% |
| Gross Margin | 44.64% | 54.12% | 27.04% | 27.49% |
| Cash Conversion Ratio | 0.01 | 2.18 | 0.75 | 1.22 |
| Growth | ||||
| Revenue 3-Year CAGR | 13.91% | 33.01% | 23.21% | 20.23% |
| Free Cash Flow Growth | -109.34% | 161.14% | -38.14% | -170.66% |
| Safety | ||||
| Net Debt / EBITDA | -4.53 | -2.93 | 0.71 | 1.63 |
| Interest Coverage | -14.14 | 24.21 | -633.79 | -578.89 |
| Efficiency | ||||
| Inventory Turnover | 6.93 | 7.65 | 5.49 | 7.22 |
| Cash Conversion Cycle | 105.37 | 64.14 | 91.45 | 128.26 |